About Monteris
Monteris is a Healthcare company based in Plymouth (United States) founded in 1999. It operates as a MRI-guided laser ablation tools for neurosurgery are developed. It operates in the Healthcare and Industrial Goods & Manufacturing sectors. Monteris has raised $199.38 million across 20 funding rounds from investors including Oxford Finance, BDC and Madryn Asset Management. The company has 100 employees. Monteris offers products and services including NeuroBlate System, Fusion Software, TruTemp Technology, and FullFire Laser Probe. Its focus areas include High Tech, Professional Service Robots, Surgery and Brain Surgery. Its legal entity is MONTERIS MEDICAL CORPORATION. Its competitors include Neo, TechsoMed, Symmetry Surgical, AiM Medical Robotics and Domain Surgical and 3 more; 5 of its 8 listed competitors have raised funding.
Company details
Monteris Medical was founded in 1999 and is headquartered in Plymouth, United States. Operations center on the development of MRI-guided neurosurgical ablation tools and solutions targeted at neurosurgeons. Magnetic Resonance Imaging (MRI), advanced navigation software, and Laser Interstitial Thermal Therapy (LITT) are integrated to enable access to various brain regions. The focus remains on minimally invasive robotic laser thermotherapy within the medical device sector.
- Headquarters Plymouth, United States
- Employees 100
- SectorsHealthcareIndustrial Goods & Manufacturing
- Website monteris.com
- Social LinkedIn X Facebook
- Legal Name Monteris Medical Corporation
- Total Equity Funding$199.38M (USD)
in 20 rounds
- Latest Funding Round$28M (USD), Series E
Mar 2026
- InvestorsOxford Finance
& 12 more
- Employee Count100
Products & Services of Monteris
Monteris offers a comprehensive portfolio of products and services, including NeuroBlate System, Fusion Software, TruTemp Technology, and FullFire Laser Probe.
Robotic MR-guided laser for brain tumor ablation
Imaging tool for neurosurgical procedures
Temperature control during laser ablation
Small probe for precise brain surgery
Funding Insights of Monteris
Monteris has successfully raised a total of $199.38M across 20 strategic funding rounds. The most recent funding activity was a Series E round of $28 million completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $199.38M
- Total Rounds 20
- Last Round Series E — $28M
- First Round $925,036
(Mar 2008)
- Investors Count 13
Latest 10 of 20 funding rounds of Monteris with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2026 | $35M | Debt – Conventional | – | – | |
| Mar 2026 | $28M | Series E | – | InnovaHealth Partners, Birchview Capital | |
| Oct 2022 | $38M | Debt – Conventional | – | – | |
| Oct 2022 | $35M | Series D | – | InnovaHealth Partners | |
| Sep 2022 | $13.7M | Series D | – | – | – |
| Sep 2020 | $9M | Series D | – | – | – |
| Mar 2020 | $2.5M | Series C | – | – | – |
| Mar 2019 | $10.68M | Series C | – | – | – |
| Jun 2017 | $26.6M | Series C | – | Versant Ventures, SightLine Partners | |
| Nov 2016 | $6.83M | Series B | – | – | – |
13 investors in total: 13 institutional.
Investors in Monteris
Monteris has secured backing from 13 investors, including institutional and venture fund investors. Prominent investors backing the company include Oxford Finance, BDC and Madryn Asset Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999. | – | versantventures.com | - | |
Sightline Partners is focused on secondary buyouts and joint ventures in healthcare. | 2004 | sightlinepartners.com | Bloomington, United States | |
Venture debt firm focused on the life sciences sector | 2002 | oxfordfinance.com | Alexandria, United States | |
Investments in early and late-stage US companies are made. | – | vertical-group.com | Basking Ridge, United States | |
InnovaHealth Partners is focused on medical device private equity investments. | – | innovahealthpartners.com | New York City, United States | |
Business growth and value creation are facilitated by Birchview Capital. | 2021 | birchviewcapital.ca | Canada | |
- | – | cuvcfund.com | - | |
Diversified asset management is provided by the firm. | 2017 | madrynlp.com | New York, United States | |
Commercial banking services for small and medium-sized enterprises are provided. | 1944 | bdc.ca | Montreal, Canada | |
Operates as a hedge fund specializing in long-short equity strategies. | 2012 | birchviewcapital.com | Burlington, United States |
Investor details for Monteris
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Monteris
35 people are tracked at Monteris (9 in leadership, 6 in board & advisors, 20 in team); the tracked headcount is 100.
| Name | Role | Group |
|---|---|---|
Aaron Deitcher | General Manager - Senior Director Of Software | Leadership |
Lisa Hayden | SVP, Market Access & Chief Compliance Officer | Leadership |
Jared Hayman | VP, North American Sales | Leadership |
James Erickson | CFO | Leadership |
Martin J. Emerson | President & CEO | Leadership |
Erik Epple | Director Of Regional Sales - Central | Leadership |
Eric Andrews | Vice President Of Engineering | Leadership |
Emily A. Smith | Vice President, Marketing | Leadership |
Michelle Bergstrom | Sr. Director Of Quality & Regulatory | Leadership |
Richard Emmitt | Director | Board & advisors |
Mortimer Berkowitz III | Director | Board & advisors |
John McCormick | Director | Board & advisors |
Andrew Joiner | Director | Board & advisors |
Matt Strobeck | Director | Board & advisors |
Jean-François Pariseau | Director | Board & advisors |
Swati Sahu | Sr. Manager, Software R&d | Team |
Troy Sorum | Sr. Marketing Manager | Team |
Richard Tyc | SVP, Science & Technology | Team |
Ryan Martinez | Capital Sales Manager - West | Team |
Fabien Costantini | Principal Software Developer | Team |
15 more people are available in the full profile.
Complete people profiles for Monteris
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Monteris
3 dated milestones of Monteris across 27 years, from founding to its latest funding, stage changes and deals.
- Founded Monteris is founded.
- Funding First funding round of $925K.
- Funding Latest funding round, Series E, of $28.0M.
Competitors of Monteris
Monteris has 8 listed competitors in our database, 5 of them funded. They include Neo, TechsoMed, Symmetry Surgical, AiM Medical Robotics and Domain Surgical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| neo.org | 2014 | Shanghai, China | – | 40 | Blockchain infrastructure is utilized for developing decentralized applications. | |
| techsomed.com | 2012 | Rehovot, Israel | $9.6M | – | Ultrasound-based monitoring systems for thermal ablation procedures are developed. | |
| symmetrysurgical.com | 1976 | Nashville, United States | – | 203 | Surgical instruments, sterilization solutions and electrosurgical products | |
| aimmedicalrobotics.com | 2018 | Fort Lauderdale, United States | $11.69M | – | Intraoperative precision robotics for neurosurgery are developed. | |
| domainsurgical.com | 2009 | Salt Lake, United States | $41.04M | – | Surgical products for soft tissue cutting | |
| misonix.com | 1959 | Farmingdale, United States | – | 1,013 | Ultrasonic surgical devices for neurosurgical, spinal, advanced wound care and general surgery | |
| venclose.com | 2014 | San Jose, United States | $27.1M | – | Radiofrequency ablation system for treating venous reflux disease | |
| aquaendoscopy.com | 2016 | Santa Ana, United States | $22.2M | – | Endoscopic ablation therapy for gastrointestinal diseases is developed. |
Detailed competitors of Monteris
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Monteris
The website of Monteris (monteris.com) receives about 5.3K visits a month.
- Monthly visits5.3K
▲ 76.7% vs previous month
Websites whose visitors overlap most with Monteris. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
hospimedica.com | hospimedica.com | 100% | – | #10,548,999 | – |
Top companies in Neurology
10 companies that operate in the same segment as Monteris (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | 541 | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Monteris
Complete news archive for Monteris
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Monteris
Monteris was founded in 1999 and raised its 1st funding round 9 years after it was founded.
Monteris is headquartered in Plymouth, United States. It is registered at Plymouth, Massachusetts, United States.
Monteris is a funded company, having raised a total of $199.38M across 20 funding rounds to date. The company's 1st funding round was a Series B of $6.83M, raised on Mar 2008.
Monteris has 100 employees.
Monteris Medical was founded in 1999 and is headquartered in Plymouth, United States. Operations center on the development of MRI-guided neurosurgical ablation tools and solutions targeted at neurosurgeons. Magnetic Resonance Imaging (MRI), advanced navigation software, and Laser Interstitial Thermal Therapy (LITT) are integrated to enable access to various brain regions. The focus remains on minimally invasive robotic laser thermotherapy within the medical device sector.
Monteris offers NeuroBlate System, Fusion Software, TruTemp Technology, and FullFire Laser Probe.
Monteris has 13 investors. Key investors include Oxford Finance, BDC, Madryn Asset Management, Southwest Michigan First, and Versant Ventures.
Monteris operates through Monteris Medical Corporation.